Abstract
This article reviews if local immunosuppression of atopic dermatitis is associated with an increased risk of cancer - as implicated by a warning issued by the FDA and EMEA health authorities because systemic immunosuppression of transplanted patients leads to a significant increase of non-melanoma skin cancer and lymphoma. So far, no studies support that the use of topical immunosuppression increases the risk of local or systemic cancer.
| Bidragets oversatte titel | Topical immune modulation and risk of cancer |
|---|---|
| Originalsprog | Dansk |
| Tidsskrift | Ugeskrift for Laeger |
| Vol/bind | 171 |
| Udgave nummer | 35 |
| Sider (fra-til) | 2468-71 |
| Antal sider | 4 |
| ISSN | 0041-5782 |
| Status | Udgivet - 24 aug. 2009 |
Emneord
- Administration, Topical
- Adult
- Child
- Dermatitis, Atopic
- Humans
- Immunosuppressive Agents
- Lymphoma
- Risk Factors
- Skin Neoplasms
- Tacrolimus